TrialBMC pulmonary medicine2016

Effects of indacaterol/glycopyrronium (QVA149) on lung hyperinflation and physical activity in patients with moderate to severe COPD: a randomised, placebo-controlled, crossover study (The MOVE Study).

Henrik Watz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.